个人中心 - 老虎社区

Godofwar

IP属地：未知

帖子 · 7帖子 · 7
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- GodofwarGodofwar
  ·2021-12-22
  $iSpecimen Inc.(ISPC)$to the 🌙
  3,516 评论
  2
  分享
  举报
- GodofwarGodofwar
  ·2021-11-26
  Great
  非常抱歉，此主贴已删除
  2,645 评论
  1
  分享
  举报
- GodofwarGodofwar
  ·2021-11-26
  Good
  EU regulator authorizes Pfizer’s COVID vaccine for kids 5-11<blockquote>欧盟监管机构批准辉瑞公司为5-11岁儿童接种COVID疫苗</blockquote>
  THE HAGUE, Netherlands (AP) — The European Union’s drug regulator on Thursday authorized Pfizer’scor
  EU regulator authorizes Pfizer’s COVID vaccine for kids 5-11<blockquote>欧盟监管机构批准辉瑞公司为5-11岁儿童接种COVID疫苗</blockquote>
  2,305 评论
  2
  分享
  举报
- GodofwarGodofwar
  ·2021-11-26
  Bravo
  It’s Not Too Late to Start Buying Lucid Stock<blockquote>现在开始购买Lucid股票还为时不晚</blockquote>
  The rewards outweigh the risks in LCID stock as the EV maker racks up some well-deserved praise
  It’s Not Too Late to Start Buying Lucid Stock<blockquote>现在开始购买Lucid股票还为时不晚</blockquote>
  4,016 1
  1
  分享
  举报
- GodofwarGodofwar
  ·2021-11-26
  Good
  非常抱歉，此主贴已删除
  3,231 1
  5
  分享
  举报
- GodofwarGodofwar
  ·2021-11-20
  $Lucid Group Inc(LCID)$57 or higher?
  3,002 1
  4
  分享
  举报
- GodofwarGodofwar
  ·2021-11-13
  $Paysafe Ltd(PSFE)$https://youtu.be/atB1eT4ulzMCrypto mass adoption with Paysafe 🚀🚀🚀
  2,982 评论
  点赞
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4098667969527850","uuid":"4098667969527850","gmtCreate":1635564902467,"gmtModify":1636668966109,"name":"Godofwar","pinyin":"godofwar","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/7da0fe8b6e1021a11796e6d327448fb6","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":5,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.29","exceedPercentage":"80.74%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"93.15%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":691861560,"gmtCreate":1640167233634,"gmtModify":1640167233766,"author":{"id":"4098667969527850","authorId":"4098667969527850","name":"Godofwar","avatar":"https://static.tigerbbs.com/7da0fe8b6e1021a11796e6d327448fb6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098667969527850","authorIdStr":"4098667969527850"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/ISPC\">$iSpecimen Inc.(ISPC)$</a>to the 🌙","listText":"<a href=\"https://laohu8.com/S/ISPC\">$iSpecimen Inc.(ISPC)$</a>to the 🌙","text":"$iSpecimen Inc.(ISPC)$to the 🌙","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691861560","isVote":1,"tweetType":1,"viewCount":3516,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877157956,"gmtCreate":1637902757694,"gmtModify":1637902757811,"author":{"id":"4098667969527850","authorId":"4098667969527850","name":"Godofwar","avatar":"https://static.tigerbbs.com/7da0fe8b6e1021a11796e6d327448fb6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098667969527850","authorIdStr":"4098667969527850"},"themes":[],"title":"","htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877157956","repostId":"2186390966","repostType":4,"isVote":1,"tweetType":1,"viewCount":2645,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877154582,"gmtCreate":1637902721646,"gmtModify":1637902722283,"author":{"id":"4098667969527850","authorId":"4098667969527850","name":"Godofwar","avatar":"https://static.tigerbbs.com/7da0fe8b6e1021a11796e6d327448fb6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098667969527850","authorIdStr":"4098667969527850"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877154582","repostId":"1101437480","repostType":4,"repost":{"id":"1101437480","kind":"news","pubTimestamp":1637896166,"share":"https://www.laohu8.com/m/news/1101437480?lang=zh_CN&edition=full","pubTime":"2021-11-26 11:09","market":"us","language":"en","title":"EU regulator authorizes Pfizer’s COVID vaccine for kids 5-11<blockquote>欧盟监管机构批准辉瑞公司为5-11岁儿童接种COVID疫苗</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1101437480","media":"APNews","summary":"THE HAGUE, Netherlands (AP) — The European Union’s drug regulator on Thursday authorized Pfizer’scor","content":"<p>THE HAGUE, Netherlands (AP) — The European Union’s drug regulator on Thursday authorized Pfizer’scoronavirusvaccine for use on children from 5 to 11 years old, clearing the way for shots to be administered to millions of elementary school pupils amid a new wave of infections sweeping across the continent.</p><p><blockquote>荷兰海牙（美联社）--欧盟药品监管机构周四批准辉瑞公司的冠状病毒疫苗用于 5 至 11 岁的儿童，为在席卷欧洲大陆的新一波感染浪潮中为数百万小学生接种疫苗扫清了道路。</blockquote></p><p> It is the first time the European Medicines Agency has cleared a COVID-19 vaccine for use in young children.</p><p><blockquote>这是欧洲药品管理局首次批准新冠肺炎疫苗用于幼儿。</blockquote></p><p> The agency said it “recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 5 to 11.”</p><p><blockquote>该机构表示，它 “建议延长 COVID-19 疫苗 Comirnaty 的适应症，将 5 至 11 岁儿童的使用范围”。</blockquote></p><p> After evaluating a study of the vaccine in more than 2,000 children, the EMA estimated that the vaccine was about 90% effective in preventing symptomatic COVID-19 in young children and said the most common side effects were pain at the injection site, headaches, muscle pain and chills. The agency said the two-dose regimen should be given to children three weeks apart.</p><p><blockquote>在评估了对2000多名儿童的疫苗研究后，EMA估计该疫苗在预防幼儿有症状的新冠肺炎方面的有效性约为90%，并表示最常见的副作用是注射部位疼痛、头痛、肌肉疼痛和发冷。该机构表示，两剂方案应间隔三周给儿童服用。</blockquote></p><p> At least one country facing spiking infections didn’t wait for the EMA approval. Authorities in the Austrian capital, Vienna, already have begun vaccinating the 5 to 11 age group. Europe is currently at the epicenter of the pandemic and the World Health Organization has warned the continent could see deaths top 2 million by the spring unless urgent measures are taken.</p><p><blockquote>至少有一个面临感染激增的国家没有等待欧洲药品管理局的批准。奥地利首都维也纳当局已经开始为5至11岁的年龄组接种疫苗。欧洲目前处于疫情的中心，世界卫生组织警告说，除非采取紧急措施，否则到春季，欧洲大陆的死亡人数可能会超过200万。</blockquote></p><p> The EMA green light for the vaccine developed by Pfizer and German company BioNTech has to be rubber-stamped by the EU’s executive branch, the European Commission, before health authorities in member states can begin administering shots.</p><p><blockquote>辉瑞公司和德国 BioNTech 公司研发的疫苗必须得到欧盟行政部门欧盟委员会的橡皮图章，才能开始注射。</blockquote></p><p> Earlier this week, Germany’s health minister Jens Spahn said shipping of vaccines for younger children in the EU would begin on Dec. 20.</p><p><blockquote>本周早些时候，德国卫生部长延斯-施潘（Jens Spahn）表示，将于12月20日开始向欧盟幼儿运送疫苗。</blockquote></p><p> The United States signed off on Pfizer’s kids-sized shots earlier this month, followed by other countries including Canada.</p><p><blockquote>本月早些时候，美国签署了辉瑞公司的儿童疫苗，随后包括加拿大在内的其他国家也签署了协议。</blockquote></p><p> Pfizer tested a dose that is a third of the amount given to adults for elementary school-age children. Even with the smaller shot, children who are 5 to 11 years old developed coronavirus-fighting antibody levels just as strong as teenagers and young adults getting the regular-strength shots, Dr. Bill Gruber, a Pfizer senior vice president, told The Associated Press in September.</p><p><blockquote>辉瑞公司对小学学龄儿童测试的剂量是成人剂量的三分之一。辉瑞公司高级副总裁比尔·格鲁伯 (Bill Gruber) 博士在 9 月份告诉美联社，即使注射较小的疫苗，5 至 11 岁的儿童产生的抗冠状病毒抗体水平也与注射常规强度疫苗的青少年和年轻人一样强。</blockquote></p><p> But the studies done on Pfizer’s vaccine in children haven’t been big enough to detect any rare side effects from the second dose, like the chest and heart inflammation that has been seen in mostly male older teens and young adults.</p><p><blockquote>但对辉瑞公司疫苗在儿童身上进行的研究还不足以发现第二剂疫苗的任何罕见副作用，如胸部和心脏炎症，这种炎症主要见于男性大龄青少年和年轻人。</blockquote></p><p> American officials noted that COVID-19 has caused more deaths in children in the 5 to 11 age group than some other diseases, such as chickenpox, did before children were routinely vaccinated.</p><p><blockquote>美国官员指出，在儿童常规接种疫苗之前，新冠肺炎在 5 至 11 岁年龄段儿童中造成的死亡人数超过了水痘等其他一些疾病。</blockquote></p><p> Earlier this month, the EMA said it began evaluating the use of Moderna Inc.’s COVID-19 vaccine for children ages 6 to 11; it estimated that a decision would be made within two months.</p><p><blockquote>本月早些时候，欧洲药品管理局表示已开始评估 Moderna 公司的 COVID-19 疫苗在 6 至 11 岁儿童中的使用情况；它估计将在两个月内做出决定。</blockquote></p><p> Although children mostly only get mild symptoms of COVID-19, some public health experts believe immunizing them should be a priority to reduce the virus’ continued spread, which could theoretically lead to the emergence of a dangerous new variant.</p><p><blockquote>虽然儿童大多只会出现轻微的 COVID-19 症状，但一些公共卫生专家认为，为他们接种疫苗应该是减少病毒继续传播的优先事项，理论上这可能会导致危险的新变种的出现。</blockquote></p><p> Researchers disagree on how much kids have influenced the course of the pandemic. Early research suggested they didn’t contribute much to viral spread. But some experts say children played a significant role this year spreading contagious variants such as alpha and delta.</p><p><blockquote>研究人员对孩子们在多大程度上影响了疫情的进程存在分歧。早期研究表明，它们对病毒传播的贡献并不大。但一些专家表示，儿童今年在传播阿尔法和德尔塔等传染性变种方面发挥了重要作用。</blockquote></p><p> In a statement this week, WHO said that because children and teens tend to have milder COVID-19 disease than adults, “it is less urgent to vaccinate them than older people, those with chronic health conditions and health workers.”</p><p><blockquote>世卫组织在本周的一份声明中说，由于儿童和青少年的 COVID-19 疾病往往比成年人轻，因此 “为他们接种疫苗的紧迫性不如老年人、慢性病患者和卫生工作者”。</blockquote></p><p> It has appealed to rich countries to stop immunizing children and asked them to donate their doses immediately to poor countries who have yet to give a first vaccine dose to their health workers and vulnerable populations.</p><p><blockquote>它呼吁富裕国家停止给儿童接种疫苗，并要求他们立即将疫苗捐赠给尚未为卫生工作者和弱势群体接种第一剂疫苗的贫穷国家。</blockquote></p><p> Still, WHO acknowledged that there are benefits to vaccinating children and adolescents that go beyond the immediate health benefits.</p><p><blockquote>尽管如此，世卫组织承认，给儿童和青少年接种疫苗的好处超出了直接的健康益处。</blockquote></p><p> “Vaccination that decreases COVID transmission in this age group may reduce transmission from children and adolescents to older adults, and may help reduce the need for mitigation measures in schools,” WHO said.</p><p><blockquote>“世卫组织说：”减少这一年龄组COVID传播的疫苗可能会减少从儿童和青少年到老年人的传播，并可能有助于减少学校采取缓解措施的必要性。</blockquote></p><p></p>","source":"lsy1628146357131","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU regulator authorizes Pfizer’s COVID vaccine for kids 5-11<blockquote>欧盟监管机构批准辉瑞公司为5-11岁儿童接种COVID疫苗</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU regulator authorizes Pfizer’s COVID vaccine for kids 5-11<blockquote>欧盟监管机构批准辉瑞公司为5-11岁儿童接种COVID疫苗</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">APNews</strong><span class=\"h-time small\">2021-11-26 11:09</span>\n</p>\n</h4>\n</header>\n<article>\n<p>THE HAGUE, Netherlands (AP) — The European Union’s drug regulator on Thursday authorized Pfizer’scoronavirusvaccine for use on children from 5 to 11 years old, clearing the way for shots to be administered to millions of elementary school pupils amid a new wave of infections sweeping across the continent.</p><p><blockquote>荷兰海牙（美联社）--欧盟药品监管机构周四批准辉瑞公司的冠状病毒疫苗用于 5 至 11 岁的儿童，为在席卷欧洲大陆的新一波感染浪潮中为数百万小学生接种疫苗扫清了道路。</blockquote></p><p> It is the first time the European Medicines Agency has cleared a COVID-19 vaccine for use in young children.</p><p><blockquote>这是欧洲药品管理局首次批准新冠肺炎疫苗用于幼儿。</blockquote></p><p> The agency said it “recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 5 to 11.”</p><p><blockquote>该机构表示，它 “建议延长 COVID-19 疫苗 Comirnaty 的适应症，将 5 至 11 岁儿童的使用范围”。</blockquote></p><p> After evaluating a study of the vaccine in more than 2,000 children, the EMA estimated that the vaccine was about 90% effective in preventing symptomatic COVID-19 in young children and said the most common side effects were pain at the injection site, headaches, muscle pain and chills. The agency said the two-dose regimen should be given to children three weeks apart.</p><p><blockquote>在评估了对2000多名儿童的疫苗研究后，EMA估计该疫苗在预防幼儿有症状的新冠肺炎方面的有效性约为90%，并表示最常见的副作用是注射部位疼痛、头痛、肌肉疼痛和发冷。该机构表示，两剂方案应间隔三周给儿童服用。</blockquote></p><p> At least one country facing spiking infections didn’t wait for the EMA approval. Authorities in the Austrian capital, Vienna, already have begun vaccinating the 5 to 11 age group. Europe is currently at the epicenter of the pandemic and the World Health Organization has warned the continent could see deaths top 2 million by the spring unless urgent measures are taken.</p><p><blockquote>至少有一个面临感染激增的国家没有等待欧洲药品管理局的批准。奥地利首都维也纳当局已经开始为5至11岁的年龄组接种疫苗。欧洲目前处于疫情的中心，世界卫生组织警告说，除非采取紧急措施，否则到春季，欧洲大陆的死亡人数可能会超过200万。</blockquote></p><p> The EMA green light for the vaccine developed by Pfizer and German company BioNTech has to be rubber-stamped by the EU’s executive branch, the European Commission, before health authorities in member states can begin administering shots.</p><p><blockquote>辉瑞公司和德国 BioNTech 公司研发的疫苗必须得到欧盟行政部门欧盟委员会的橡皮图章，才能开始注射。</blockquote></p><p> Earlier this week, Germany’s health minister Jens Spahn said shipping of vaccines for younger children in the EU would begin on Dec. 20.</p><p><blockquote>本周早些时候，德国卫生部长延斯-施潘（Jens Spahn）表示，将于12月20日开始向欧盟幼儿运送疫苗。</blockquote></p><p> The United States signed off on Pfizer’s kids-sized shots earlier this month, followed by other countries including Canada.</p><p><blockquote>本月早些时候，美国签署了辉瑞公司的儿童疫苗，随后包括加拿大在内的其他国家也签署了协议。</blockquote></p><p> Pfizer tested a dose that is a third of the amount given to adults for elementary school-age children. Even with the smaller shot, children who are 5 to 11 years old developed coronavirus-fighting antibody levels just as strong as teenagers and young adults getting the regular-strength shots, Dr. Bill Gruber, a Pfizer senior vice president, told The Associated Press in September.</p><p><blockquote>辉瑞公司对小学学龄儿童测试的剂量是成人剂量的三分之一。辉瑞公司高级副总裁比尔·格鲁伯 (Bill Gruber) 博士在 9 月份告诉美联社，即使注射较小的疫苗，5 至 11 岁的儿童产生的抗冠状病毒抗体水平也与注射常规强度疫苗的青少年和年轻人一样强。</blockquote></p><p> But the studies done on Pfizer’s vaccine in children haven’t been big enough to detect any rare side effects from the second dose, like the chest and heart inflammation that has been seen in mostly male older teens and young adults.</p><p><blockquote>但对辉瑞公司疫苗在儿童身上进行的研究还不足以发现第二剂疫苗的任何罕见副作用，如胸部和心脏炎症，这种炎症主要见于男性大龄青少年和年轻人。</blockquote></p><p> American officials noted that COVID-19 has caused more deaths in children in the 5 to 11 age group than some other diseases, such as chickenpox, did before children were routinely vaccinated.</p><p><blockquote>美国官员指出，在儿童常规接种疫苗之前，新冠肺炎在 5 至 11 岁年龄段儿童中造成的死亡人数超过了水痘等其他一些疾病。</blockquote></p><p> Earlier this month, the EMA said it began evaluating the use of Moderna Inc.’s COVID-19 vaccine for children ages 6 to 11; it estimated that a decision would be made within two months.</p><p><blockquote>本月早些时候，欧洲药品管理局表示已开始评估 Moderna 公司的 COVID-19 疫苗在 6 至 11 岁儿童中的使用情况；它估计将在两个月内做出决定。</blockquote></p><p> Although children mostly only get mild symptoms of COVID-19, some public health experts believe immunizing them should be a priority to reduce the virus’ continued spread, which could theoretically lead to the emergence of a dangerous new variant.</p><p><blockquote>虽然儿童大多只会出现轻微的 COVID-19 症状，但一些公共卫生专家认为，为他们接种疫苗应该是减少病毒继续传播的优先事项，理论上这可能会导致危险的新变种的出现。</blockquote></p><p> Researchers disagree on how much kids have influenced the course of the pandemic. Early research suggested they didn’t contribute much to viral spread. But some experts say children played a significant role this year spreading contagious variants such as alpha and delta.</p><p><blockquote>研究人员对孩子们在多大程度上影响了疫情的进程存在分歧。早期研究表明，它们对病毒传播的贡献并不大。但一些专家表示，儿童今年在传播阿尔法和德尔塔等传染性变种方面发挥了重要作用。</blockquote></p><p> In a statement this week, WHO said that because children and teens tend to have milder COVID-19 disease than adults, “it is less urgent to vaccinate them than older people, those with chronic health conditions and health workers.”</p><p><blockquote>世卫组织在本周的一份声明中说，由于儿童和青少年的 COVID-19 疾病往往比成年人轻，因此 “为他们接种疫苗的紧迫性不如老年人、慢性病患者和卫生工作者”。</blockquote></p><p> It has appealed to rich countries to stop immunizing children and asked them to donate their doses immediately to poor countries who have yet to give a first vaccine dose to their health workers and vulnerable populations.</p><p><blockquote>它呼吁富裕国家停止给儿童接种疫苗，并要求他们立即将疫苗捐赠给尚未为卫生工作者和弱势群体接种第一剂疫苗的贫穷国家。</blockquote></p><p> Still, WHO acknowledged that there are benefits to vaccinating children and adolescents that go beyond the immediate health benefits.</p><p><blockquote>尽管如此，世卫组织承认，给儿童和青少年接种疫苗的好处超出了直接的健康益处。</blockquote></p><p> “Vaccination that decreases COVID transmission in this age group may reduce transmission from children and adolescents to older adults, and may help reduce the need for mitigation measures in schools,” WHO said.</p><p><blockquote>“世卫组织说：”减少这一年龄组COVID传播的疫苗可能会减少从儿童和青少年到老年人的传播，并可能有助于减少学校采取缓解措施的必要性。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://apnews.com/article/coronavirus-pandemic-business-health-europe-european-union-9942c26add532adc1f72e64b8708ee6e\">APNews</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://apnews.com/article/coronavirus-pandemic-business-health-europe-european-union-9942c26add532adc1f72e64b8708ee6e","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101437480","content_text":"THE HAGUE, Netherlands (AP) — The European Union’s drug regulator on Thursday authorized Pfizer’scoronavirusvaccine for use on children from 5 to 11 years old, clearing the way for shots to be administered to millions of elementary school pupils amid a new wave of infections sweeping across the continent.\nIt is the first time the European Medicines Agency has cleared a COVID-19 vaccine for use in young children.\nThe agency said it “recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 5 to 11.”\nAfter evaluating a study of the vaccine in more than 2,000 children, the EMA estimated that the vaccine was about 90% effective in preventing symptomatic COVID-19 in young children and said the most common side effects were pain at the injection site, headaches, muscle pain and chills. The agency said the two-dose regimen should be given to children three weeks apart.\nAt least one country facing spiking infections didn’t wait for the EMA approval. Authorities in the Austrian capital, Vienna, already have begun vaccinating the 5 to 11 age group. Europe is currently at the epicenter of the pandemic and the World Health Organization has warned the continent could see deaths top 2 million by the spring unless urgent measures are taken.\nThe EMA green light for the vaccine developed by Pfizer and German company BioNTech has to be rubber-stamped by the EU’s executive branch, the European Commission, before health authorities in member states can begin administering shots.\nEarlier this week, Germany’s health minister Jens Spahn said shipping of vaccines for younger children in the EU would begin on Dec. 20.\nThe United States signed off on Pfizer’s kids-sized shots earlier this month, followed by other countries including Canada.\nPfizer tested a dose that is a third of the amount given to adults for elementary school-age children. Even with the smaller shot, children who are 5 to 11 years old developed coronavirus-fighting antibody levels just as strong as teenagers and young adults getting the regular-strength shots, Dr. Bill Gruber, a Pfizer senior vice president, told The Associated Press in September.\nBut the studies done on Pfizer’s vaccine in children haven’t been big enough to detect any rare side effects from the second dose, like the chest and heart inflammation that has been seen in mostly male older teens and young adults.\nAmerican officials noted that COVID-19 has caused more deaths in children in the 5 to 11 age group than some other diseases, such as chickenpox, did before children were routinely vaccinated.\nEarlier this month, the EMA said it began evaluating the use of Moderna Inc.’s COVID-19 vaccine for children ages 6 to 11; it estimated that a decision would be made within two months.\nAlthough children mostly only get mild symptoms of COVID-19, some public health experts believe immunizing them should be a priority to reduce the virus’ continued spread, which could theoretically lead to the emergence of a dangerous new variant.\nResearchers disagree on how much kids have influenced the course of the pandemic. Early research suggested they didn’t contribute much to viral spread. But some experts say children played a significant role this year spreading contagious variants such as alpha and delta.\nIn a statement this week, WHO said that because children and teens tend to have milder COVID-19 disease than adults, “it is less urgent to vaccinate them than older people, those with chronic health conditions and health workers.”\nIt has appealed to rich countries to stop immunizing children and asked them to donate their doses immediately to poor countries who have yet to give a first vaccine dose to their health workers and vulnerable populations.\nStill, WHO acknowledged that there are benefits to vaccinating children and adolescents that go beyond the immediate health benefits.\n“Vaccination that decreases COVID transmission in this age group may reduce transmission from children and adolescents to older adults, and may help reduce the need for mitigation measures in schools,” WHO said.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2305,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877154121,"gmtCreate":1637902699733,"gmtModify":1637902699733,"author":{"id":"4098667969527850","authorId":"4098667969527850","name":"Godofwar","avatar":"https://static.tigerbbs.com/7da0fe8b6e1021a11796e6d327448fb6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098667969527850","authorIdStr":"4098667969527850"},"themes":[],"title":"","htmlText":"Bravo","listText":"Bravo","text":"Bravo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877154121","repostId":"1142519553","repostType":4,"repost":{"id":"1142519553","kind":"news","pubTimestamp":1637896860,"share":"https://www.laohu8.com/m/news/1142519553?lang=zh_CN&edition=full","pubTime":"2021-11-26 11:21","market":"us","language":"en","title":"It’s Not Too Late to Start Buying Lucid Stock<blockquote>现在开始购买Lucid股票还为时不晚</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1142519553","media":"InvestorPlace","summary":"The rewards outweigh the risks in LCID stock as the EV maker racks up some well-deserved praise","content":"<p><div> Electric vehicle startupLucid Group(NASDAQ:LCID) released its first earnings report as a publicly traded company on Nov. 15. On the surface, the numbers weren’t great. Lucid lost 42 cents per share, ...</p><p><blockquote><div>电动汽车初创公司Plucid Group（纳斯达克股票代码：LCID）于11月15日发布了作为上市公司的第一份收益报告。从表面上看，这些数字并不好。Lucid每股亏损42美分，...</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/11/why-its-not-too-late-to-start-buying-lcid-stock/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/11/why-its-not-too-late-to-start-buying-lcid-stock/\">网页连接</a></blockquote></p><p></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>It’s Not Too Late to Start Buying Lucid Stock<blockquote>现在开始购买Lucid股票还为时不晚</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIt’s Not Too Late to Start Buying Lucid Stock<blockquote>现在开始购买Lucid股票还为时不晚</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">InvestorPlace</strong><span class=\"h-time small\">2021-11-26 11:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Electric vehicle startupLucid Group(NASDAQ:LCID) released its first earnings report as a publicly traded company on Nov. 15. On the surface, the numbers weren’t great. Lucid lost 42 cents per share, ...</p><p><blockquote><div>电动汽车初创公司Plucid Group（纳斯达克股票代码：LCID）于11月15日发布了作为上市公司的第一份收益报告。从表面上看，这些数字并不好。Lucid每股亏损42美分，...</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/11/why-its-not-too-late-to-start-buying-lcid-stock/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/11/why-its-not-too-late-to-start-buying-lcid-stock/\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://investorplace.com/2021/11/why-its-not-too-late-to-start-buying-lcid-stock/\">InvestorPlace</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LCID":"Lucid Group Inc"},"source_url":"https://investorplace.com/2021/11/why-its-not-too-late-to-start-buying-lcid-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142519553","content_text":"Electric vehicle startupLucid Group(NASDAQ:LCID) released its first earnings report as a publicly traded company on Nov. 15. On the surface, the numbers weren’t great. Lucid lost 42 cents per share, dwarfing analysts’ expectations for a loss of 25 cents per share. Yet, LCID stock jumped nearly 24% the next day. It just goes to show you that you can’t always judge how investors will react to an earnings report based on the headline.\nLCID stock has been on fire over the past month, rising more than 117%. I expect shares to continue to outperform based on bullish sentiment related to production numbers, a major automotive award and analyst upgrades.\nLucid: Beyond the Loss\nLucid went public in July after closing its merger with special purpose acquisition company Churchill Capital Corp IV. It is headed by CEO Peter Rawlinson. Before working at Lucid, Rawlinson was best known as the vehicle engineer for the popular Tesla(NASDAQ:TSLA) Model S.\nLucid began delivering its first model, the Lucid Air, on Oct. 30. The electric sedan has a starting price of $77,400 and boasts a top range of 520 miles. In comparison, Tesla’s Model S sells for $91,190 and has a top range of 412 miles. Advantage Lucid.\nBuyers are lining up. Lucid announced that it had 13,000 reservations for the Lucid Air at the end of Q3. By Nov. 15, management said it had over 17,000 reservations.\nThe company believes it can produce 20,000 vehicles in 2022 at its Arizona plant.\n“This target is not without risk given ongoing challenges facing the automotive industry, with global disruptions to supply chains and logistics,” Rawlinson said in a news release. “We are taking steps to mitigate these challenges, however, and look forward to the launch of the Grand Touring, Touring, and Pure versions of Lucid Air through 2022.”\nLucid’s factory has a top capacity of 34,000 vehicles annually, but the company has already started an expansion project that will allow it to produce 90,000 vehicles by the end of 2023. It also plans to open plants in China and the Middle East by the middle of the decade.\nLucid said it ended the third quarter with a cash horde of $4.8 billion. Not bad for a new company.\nLucid Receives Industry and Analyst Praise\nEarlier this month, I wrote what could best be described as a skeptical take on LCID stock. I noted that the car was getting solid reviews from MotorTrend,Car and DriverandConsumer Reports. But the real test, I said, would be if Lucid could keep up the quality on a day-to-day basis.\nNow, at least one of those reviewers is doubling down in a big way.MotorTrendannounced on Nov. 15 that the Lucid Air is its 2022 Car of the Year:\n\n Automotive progress usually happens in baby steps. Slowly, like a white oak sapling growing in a forest. But every now and then a new car jumps off the automotive forest floor like a rainbow eucalyptus, advancing like crazy while making a colorful splash. The Air sedan from startup EV-maker Lucid is just such a car, and its level of innovation and sophistication are as fresh and unexpected as multicolored tree bark.\n\nThat’s some head-turning praise.\nOnly four analysts currently cover LCID stock,according toThe Wall Street Journal, with one-year targets ranging from a low of $16 to a high of $60. I think the high end is more realistic.\nCiti analyst Itay Michaeli recently boosted his target from $28 to $57 a share, maintaining a “buy” rating. In a research note, he wrote that Lucid has “strong” EV tech credentials that are building both commercial and brand momentum. Michaeli’s target is about 9% above the stock’s current price.\nThe Bottom Line on LCID Stock\nWith a universally hailed design, strong demand and rave reviews, Lucid’s shares are riding high right now. LCID stock has even been outpacing Tesla’s shares recently, up more than 140% over the past three months compared to 70% for TSLA stock.\nIt’s not too late to start building a position in LCID stock. The best strategy is dollar-cost averaging, or to consistently buy shares in set amounts over a period of time. Just remember that, because Lucid is a relatively new company, its shares are bound to be volatile.\nThe EV space is going to be competitive for years. Don’t overreact to peaks and valleys. All in all, the rewards seem higher than the risks right now.","news_type":1,"symbols_score_info":{"LCID":0.9}},"isVote":1,"tweetType":1,"viewCount":4016,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877152699,"gmtCreate":1637902499743,"gmtModify":1637902499743,"author":{"id":"4098667969527850","authorId":"4098667969527850","name":"Godofwar","avatar":"https://static.tigerbbs.com/7da0fe8b6e1021a11796e6d327448fb6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098667969527850","authorIdStr":"4098667969527850"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877152699","repostId":"2186318463","repostType":4,"isVote":1,"tweetType":1,"viewCount":3231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876443353,"gmtCreate":1637348338674,"gmtModify":1637348338745,"author":{"id":"4098667969527850","authorId":"4098667969527850","name":"Godofwar","avatar":"https://static.tigerbbs.com/7da0fe8b6e1021a11796e6d327448fb6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098667969527850","authorIdStr":"4098667969527850"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>57 or higher?","listText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>57 or higher?","text":"$Lucid Group Inc(LCID)$57 or higher?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876443353","isVote":1,"tweetType":1,"viewCount":3002,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879586989,"gmtCreate":1636738373246,"gmtModify":1636754551993,"author":{"id":"4098667969527850","authorId":"4098667969527850","name":"Godofwar","avatar":"https://static.tigerbbs.com/7da0fe8b6e1021a11796e6d327448fb6","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098667969527850","authorIdStr":"4098667969527850"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/PSFE\">$Paysafe Ltd(PSFE)$</a>https://youtu.be/atB1eT4ulzMCrypto mass adoption with Paysafe&nbsp;🚀🚀🚀","listText":"<a href=\"https://laohu8.com/S/PSFE\">$Paysafe Ltd(PSFE)$</a>https://youtu.be/atB1eT4ulzMCrypto mass adoption with Paysafe&nbsp;🚀🚀🚀","text":"$Paysafe Ltd(PSFE)$https://youtu.be/atB1eT4ulzMCrypto mass adoption with Paysafe 🚀🚀🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879586989","isVote":1,"tweetType":1,"viewCount":2982,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}